Bridgewater Associates’s Natus Medical Inc NTUS Stock Holding History

Bridgewater Associates’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54,101	Closed	-$1.77M	–	1045
2022 Q2	$1.77M	Buy	54,101 +5,103	+10%	+$161K	0.01%	704
2022 Q1	$1.29M	Buy	48,998 +11,520	+31%	+$281K	0.01%	767
2021 Q4	$889K	Buy	37,478 +1,554	+4%	+$38.4K	0.01%	593
2021 Q3	$901K	Buy	35,924 +72	+0.2%	+$1.83K	﹤0.01%	533
2021 Q2	$931K	Buy	+35,852	New	+$975K	0.01%	602

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgewater Associates's NTUS Position: Q3 2022 in Review

Bridgewater Associates sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 54,101 shares — an estimated $1.77M sold.

Bridgewater Associates first reported a position in NTUS in Q2 2021 and held it in 5 quarters. The position peaked at $1.77M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Bridgewater Associates reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Bridgewater Associates sold 54,101 Natus Medical Inc shares in Q3 2022, an estimated $1.77M.
Bridgewater Associates first reported a position in Natus Medical Inc in Q2 2021 and held it in 5 quarters.
Bridgewater Associates's Natus Medical Inc position peaked at $1.77M in Q2 2022.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.